Anbio Biotechnology share price logo

Anbio Biotechnology Share Price

NASDAQ: NNNN

Large Cap

$42.79

+0.24

(+0.56%)

Live

as on

Anbio Biotechnology Stock Performance

as on September 17, 2025 at 12:30 am IST

  • Day's Low

    Day's High

    $41.7
    $44.09
    downward going graph

    2.55%

    Downside

    3.04%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $5.18
    $55.65
    downward going graph

    87.89%

    Downside

    30.05%

    Upside

    downward going graph

Anbio Biotechnology share price movements today

Previous Close
$42.55
Open
$44.09
Volume
145.0K
Day's Low - High
$41.7 - $44.09
52 Week Low - High
$5.18 - $55.65

Anbio Biotechnology Historical Returns

1 Month Return
-16.42 %
3 Month Return
+ 372.25 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Anbio Biotechnology Stock Fundamentals & Key Indicators

Check Anbio Biotechnology market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.3B

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

858.33

P/B Ratio

858.3334

PEG Ratio

0

Return On Equity TTM

14.83%

Anbio Biotechnology vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Anbio Biotechnology with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
NA$2.3BNA858.3328.99%
BUY$161.2B88.31%62.928.51%
BUY$39.7B55.8%28.427.22%
BUY$38.9B31.65%36.2510.70%
BUY$18.5B-8.44%37.8716.48%

Anbio Biotechnology Stock's Interest Amongst Investors

Search interest for Anbio Biotechnology Stock has decreased by -52% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-52% versus previous 30 day period

Anbio Biotechnology Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Dec 2023
Jun 2024
Dec 2024
Total Revenue
3
3
6
2
Gross Profit
1
1
4
2
Operating Income
1
0
3
-1
EBITDA
1
0
3
-1
Interest Expense
-
-
-
-
Depreciation
-
-
-
-
Income Before Tax
1
0
3
-1
Income Tax Expense
-
-
-
-
Net Income
1
0
3
-1
Net Profit Margin
49.70%
20.07%
61.48%
-52.40%

Anbio Biotechnology Annual Profit & Loss

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
4
23
6
8
Gross Profit
2
12
3
5
Operating Income
2
10
1
1
EBITDA
2
10
2
2
Interest Expense
-
0
-
-
Depreciation
-
0
0
-
Income Before Tax
2
10
2
2
Income Tax Expense
-
-
-
-
Net Income
2
10
2
2
Net Profit Margin
57.26%
42.52%
33.58%
28.99%

Anbio Biotechnology Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Jun 2024
Dec 2024
Net Income
0
3
-1
Operating Cash Flow
-1
0
1
Investing Cash Flow
0
0
0
Financing Cash Flow
0
0
0
Change in Cash
-
-
-

Anbio Biotechnology Annual Cash Flow

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Net Income
10
2
2
Operating Cash Flow
4
0
2
Investing Cash Flow
-1
1
0
Financing Cash Flow
-
0
0
Change in Cash
2
2
2

Insights on Anbio Biotechnology

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, NNNN stock has moved up by 379.2%

About Anbio Biotechnology

Anbio Biotechnology is a Germany-based company. The Company is engaged in the development of medical technology and the provision of in vitro diagnostics (IVD) products. Its products encompasses solutions for various applications, including over-the-counter (OTC) utilization, point-of-care (POCT) settings, and laboratory applications. The Company's product detects biomarkers associated with medical domains. These domains encompasses infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. In addition, the Company's IVD products are in line with multiple sample collection matrices, including serum, plasma, whole blood, feces, urine, and saliva, for both healthcare providers and patients. Its primary research and development activities for all IVD products includes Biomarker Discovery and Validation, Assay Development, Validation - Clinical and Analytical and Platform Transfer.
OrganisationAnbio Biotechnology
HeadquartersWilhelm Gutbrod Str 21B, Frankfurt am Main, Germany, 60437
CEOMr. Michael Lau M.B.A., Ph.D.
E-voting on sharesClick here to vote

Key Management of Anbio Biotechnology

Name

Title

Mr. Michael Lau M.B.A., Ph.D.

Chief Executive Officer

Ms. Suki Song CPA

Chief Financial Officer

Mr. Chris Tian

Chief Business Officer

FAQs

What is Anbio Biotechnology share price today?

Anbio Biotechnology share price today is $42.79 as on . Anbio Biotechnology share today touched a day high of $44.09 and a low of $41.7.

What is the 52 week high and 52 week low for Anbio Biotechnology share?

Anbio Biotechnology share touched a 52 week high of $55.65 on and a 52 week low of $5.18 on . Anbio Biotechnology stock price today i.e. is trending at $42.79,which is 23.11% down from its 52 week high and 726.06% up from its 52 week low.

What is Anbio Biotechnology's market capitalisation today?

Anbio Biotechnology market capitalisation is $0.00T as on .

How to invest in Anbio Biotechnology Stock (NNNN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Anbio Biotechnology on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Anbio Biotechnology Shares that will get you 0.0351 shares as per Anbio Biotechnology share price of $42.79 per share as on September 17, 2025 at 12:30 am IST.

What is the minimum amount required to buy Anbio Biotechnology Stock (NNNN) from India?

Indian investors can start investing in Anbio Biotechnology (NNNN) shares with as little as ₹88.042 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Anbio Biotechnology stock (as per the Rupee-Dollar exchange rate as on ). Based on Anbio Biotechnology share’s latest price of $42.79 as on September 17, 2025 at 12:30 am IST, you will get 0.2337 shares of Anbio Biotechnology. Learn more about fractional shares .